Antimicrobial Sensitivity Patterns of Pseudomonas aeruginosa Isolates Obtained From Foot Ulcer Diabetes Patients in Tripoli, Libya.
DOI:
https://doi.org/10.54361/Keywords:
Pseudomonas aeruginosa, diabetic foot ulcer, antibiotics resistance.Abstract
Background: Pseudomonas aeruginosa is one of the most invasive organism that causes severe tissue damage in diabetic foot ulcers. A major problem in P. aeruginosa infection because of that it is commonly exhibits a high degree of resistance to antimicrobial agents. To improve appropriate antimicrobial therapy and reduce the incidence of antibiotics resistant bacteria, information on the antibiotic susceptibility to this bacterium is urgently needed. Therefore, the aim of this study was to isolate and determinate the antimicrobial susceptibility of the P. aeruginosa in diabetic foot ulcers patients. Methods: This study was carried out over the period between June 2014 to April 2015 at Tripoli Medical Center. A total of 120 bacterial isolates were cultured onto bacteriological media such as nutrient agar, MacConkey agar and blood agar. Identification of retrieved bacterial isolates was done using standard diagnostic microbiological laboratory methods and antibiogram was determined by VITEK ® 2 compact automated system. Results: Twenty one strains of P. aeruginosa from 120 diabetic foot ulcers were detected. P. aeruginosa isolates exhibited multidrug resistance to Ampicillin, Augmenting, Cefuroxime, Cefoxitin, Cefazolin, Ceftriaxone, Trimethoprim/sulfamethzole, Piperacillin. However, all isolates of P. aeruginosa were 100 % sensitive to Imipenem. Conclusion: P. aeruginosa infections of diabetic foot ulcers patients have multi-drug resistant. Imipenem is the empirical antibiotic of the choice.
Downloads
References
Dhanasekaran G, Sastry N. G, and Mohan V, “Microbial pattern of soft-tissue infections in diabetic patients in South India,” Asian Journal of Diabetology, vol. 5, no. 5-6, pp. 8–10, 2003.
Baltimore R. S, “Pseudomonas,” inNelson Textbook of Pediatrics, pp. 862–864, 2000.
Sivanmaliappan TS, Sevanan, Antimicrobial Susceptibility Patterns of Pseudomonas aeruginosa from Diabetes Patients with Foot Ulcers. Int J Microbiol 2011: 605195.
Iglewski BH (1996) Pseudomonas. In: Baron's Medical Microbiology. (4th ed), Univ of Texas Medical Branch.
Sadikot RT, Blackwell TS, Christman JW et al. Pathogen–host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005; 171: 1209–23.
Cheesbrough M (2001) District laboratory practice in tropical countries. University Press, Cambridge, UK
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty Third Informational Supplement. CLSI document M100-S23; 2013;33:1.
El-Tahawy AT. Bacteriology of diabetic foot. Saudi Med J. 2000;21;344-7.
Sadikot RT, Blackwell TS, Christman JW et al. Pathogen–host interactions in Pseudomonas aeruginosa pneumonia. Am J RespirCritCare Med 2005; 171: 1209–23.
Mitsuhashi, S. 1983. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. J. Antimicrob. Chemother. 12(Suppl. D):53-64.
Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin. Microbiol. Infect. 2008; 14: 816–827. pmid:18844682
Noreddin AM, Elkhatib WF. Levofloxacin in the treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther. 2010;8:505–514. pmid:20455679
Castanheira M, Mills JC, Farrell DJ, Jones RN. Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals. Antimicrob Agents Chemother. 2014; 58: 6844–6850. pmid:25182652
Chaudhary M, Shrivastava SM, Varughese L, Sehgal R. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. Curr Clin Pharmacol. 2008; 3:118–122. pmid:18700304
Al Benwan KAl Mulla A, Rotimi VO A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait.J Infect Public Health .2012; 5 (1): 1-8
Shen Q, Lin D, Zhu H, Ge S, Wu W, Pan X, Gu X, Shen F. Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabetic foot infection. Zhonghua Yi XueZaZhi1. 2014; 94(12):889-94
Rastogi A, Sukumar S, Hajela A, Mukherjee S, Dutta P, Bhadada SK, Bhansali A. J Diabetes Complications. 2017; 31(2):407-412
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Abdulkareem Elbaz, A. Dhawi, Asma K. Elramalli, Ibrahim A. Algondi, Asadik Anan, Altayeb Elazomi, Mustafa Saieh (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
